1-8 of 8
solitary plasmacytoma of bone
Close
Sort by
Journal Articles

Risk of Developing Second Cancers in Plasmacytoma in United States

Vivek Kumar, MD, Neha Chaudhary, MD, Vishangi Dave, MD, Abhinav B Chandra, MD MSc, FACP
Journal: Blood
Blood (2016) 128 (22): 4443.
https://doi.org/10.1182/blood.V128.22.4443.4443
Published: 2016
Journal Articles

Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis

Clinical Trials & Observations Brief Report
Quentin A. Hill, Andy C. Rawstron, Ruth M. de Tute, Roger G. Owen
Journal: Blood
Blood (2014) 124 (8): 1296–1299.
https://doi.org/10.1182/blood-2014-04-566521
Published: 2014
Journal Articles

Polyclonal Serum FLC Levels: a Simple Risk Stratification Model for Identifying Aggressive Stage A CLL.

Guy Pratt, Alison Levoguer, Jeffrey Faint, Chris Fegan, Chris Pepper, David Graham Oscier, MD, Anne Gardiner, Stephen Harding, PhD
Journal: Blood
Blood (2010) 116 (21): 4608.
https://doi.org/10.1182/blood.V116.21.4608.4608
Published: 2010
Journal Articles

Neoplastic Plasma Cells Are Demonstrable at Bone Marrow Sites Distant to Solitary Plasmacytoma of Bone and Predict for Progression to Multiple Myeloma.

Quentin A. Hill, MD, Ruth M. de Tute, MSc, J. Anthony Child, MD, Andy C. Rawstron, PhD, Roger G. Owen, MD
Journal: Blood
Blood (2006) 108 (11): 3512.
https://doi.org/10.1182/blood.V108.11.3512.3512
Published: 2006
Journal Articles

Immunoglobulin free light chains and solitary plasmacytoma of bone

David Dingli, Robert A. Kyle, S. Vincent Rajkumar, Grzegorz S. Nowakowski, Dirk R. Larson, John P. Bida, Morie A. Gertz, Terry M. Therneau, L. Joseph Melton, III, Angela Dispenzieri, Jerry A. Katzmann
Journal: Blood
Blood (2006) 108 (6): 1979–1983.
https://doi.org/10.1182/blood-2006-04-015784
Published: 2006
Journal Articles

Immunoglobulin Free Light Chains at Diagnosis: Predictors of Progression and Survival in Solitary Plasmacytoma of Bone.

David Dingli, MD, PhD, Robert A. Kyle, MD, Vincent S. Rajkumar, MD, Grzegorz S. Nowakowski, MD, Dirk R. Larson, MS, John P. Bida, MA, Morie A. Gertz, MD, Angela Dispenzieri, MD, L. J. Melton, III, MD, Terry M. Therneau, PhD, Jerry A. Katzmann, PhD
Journal: Blood
Blood (2005) 106 (11): 5080.
https://doi.org/10.1182/blood.V106.11.5080.5080
Published: 2005
Journal Articles

Low Incidence of Complete Remission but Comparable Event-Free Survival(EFS) and Overall Survival (OS) with a History of Prior Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Myeloma (SMM) among Patients Receiving Total Therapy 2 (TT 2).

Athanasios Fassas, MD, Bart Barlogie, MD, PhD, Erik Rasmussen, Teresa Milner, Julian Terry, Maurizio Zangari, MD, Giampaolo Talamo, MD, Choon-Kee Lee, MD, Raymond Thertulien, MD, PhD, John Crowley, PhD, Guido Tricot, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 932.
https://doi.org/10.1182/blood.V104.11.932.932
Published: 2004
Journal Articles

Solitary plasmacytoma of bone and asymptomatic multiple myeloma

Clinical Trials & Observations
Meletios A. Dimopoulos, Lia A. Moulopoulos, Alice Maniatis, Raymond Alexanian
Journal: Blood
Blood (2000) 96 (6): 2037–2044.
https://doi.org/10.1182/blood.V96.6.2037
Published: 2000